Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ION464 Administered to Adults With Multiple System Atrophy (HORIZON)
Clinical trial NCT04165486 · RECRUITING
Trial details
- NCT number
- NCT04165486
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-21
- Primary completion
- 2027-09-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.